| Financial Year |
March 31 2023 |
| Monetary Funds |
516,592,117.58 |
| Held-for-trading Financial Assets |
264,000.00 |
| Notes Receivable |
135,473.44 |
| Accounts Receivable |
222,125,877.34 |
| Advances to Suppliers |
15,858,242.83 |
| Other Receivables |
13,756,079.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
345,026,381.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,958,243.97 |
| Total Current Assets |
1,193,470,622.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,079,675.30 |
| Investment Properties |
-- |
| Fixed Assetes |
635,661,298.11 |
| Under-construction Projects |
11,870,972.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
390,283,762.50 |
| R&D expenses |
-- |
| Goodwill |
2,905,993,573.87 |
| Long-Term Deferred and Prepaid Expenses |
6,908,828.23 |
| Deferred Income Tax Assets |
41,742,242.13 |
| Other Non-Current Assets |
319,000,000.00 |
| Sub-Total of Non-Current Assets |
4,827,880,944.50 |
| Total Assets |
6,021,351,567.48 |
| Short-Term Loans |
408,236,320.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
51,253,824.76 |
| Accounts Payable |
241,150,452.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
101,810,773.66 |
| Taxes Payable |
35,243,329.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
357,167,107.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
274,006,574.43 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,542,666,512.69 |
| Long-term Loans |
1,297,278,828.51 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,541,207.33 |
| Deferred Income Tax Liabilities |
78,484,170.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,395,592,907.46 |
| Total Liabilities |
2,938,259,420.15 |
| Paid-In Capital(Or Share Stock) |
112,000,000.00 |
| Capital Surplus |
206,341,440.42 |
| Surplus Reserve |
31,134,839.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
330,922,858.33 |
| Minority Stockholder's Interest |
2,470,803,465.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
612,288,681.57 |
| Owner's Equity（Stockholder's Equity） |
3,083,092,147.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,021,351,567.48 |
